Aduro Clean Technologies Inc. (ADUR) announced a non‑binding Letter of Intent (LOI) with a leading independent international commodity trading firm to purchase Hydrochemolytic™ oil produced at its Next Generation Process (NGP) pilot plant. The LOI, disclosed on March 12, 2026, includes a firm purchase commitment for the first production lot from the planned First‑of‑a‑Kind (FOAK) industrial plant in the Chemelot industrial park, Netherlands, and establishes a structured Pilot‑to‑FOAK validation program.
The agreement allows Aduro to provide the trading partner with samples from its pilot plant for characterization, including contaminant profiling, boiling‑point distribution and alignment with downstream steam‑cracking specifications. The trading partner has committed to purchase the first FOAK production lot, a commitment that will support downstream customer qualification, market‑development activities and demonstrate the reliability and reproducibility of the process at industrial scale.
This first commercial commitment is a significant milestone for Aduro, moving the company from a pre‑revenue, technology‑validation stage toward generating revenue and validating its Hydrochemolytic™ platform in a real‑world commercial setting. “Securing a structured offtake commitment at the FOAK stage reflects our effort to align technology validation and market demand. Circular feedstocks must meet the requirements of existing petrochemical infrastructure while also satisfying regulatory and certification standards,” said Ofer Vicus, CEO of Aduro.
In Q2 fiscal 2026 (ended November 30, 2025), Aduro reported revenue of $122,706, a 222% increase compared with $38,143 in Q2 2025, while the company recorded an operating loss of $6,461,987 versus $3,114,712 in the prior year. The growth in revenue reflects the expanding pipeline of pilot‑to‑FOAK projects and the increasing demand for certified circular feedstocks driven by EU packaging regulations.
The LOI follows the NGP pilot plant’s transition to initial operating campaigns on February 11, 2026, and the selection of the Chemelot site on January 29, 2026. Aduro also completed a U.S. public offering in January 2026 that raised approximately $20 million to advance its demonstration plant program and research and development efforts.
"The pilot stage work allows us to establish product specifications and determine commercial value of Hydrochemolytic™ oil with a global trading partner while the commitment to purchase the first FOAK production parcel establishes the product's initial commercial pathway,” added Eric Appelman, Chief Revenue Officer of Aduro.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.